Nature staff discuss how an FDA-approved drug for narcolepsy could have promise beyond the condition, and the longest-lived human brain organoids yet.00:28 The promise of a new narcolepsy drugNature: <a href="#" rel="noopener noreferrer" target="_blank">First-of-its-kind narcolepsy drug opens door to new therapies for the brain</a>05:53 Human brain organoids kept alive for over five yearsNature: <a href="#" rel="noopener noreferrer" target="_blank">Human organoids that mimic brain development grown for years in lab</a>​​​​​​​<a href="#" rel="noopener noreferrer" target="_blank">Subscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.</a><hr> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

Briefing Chat: New narcolepsy drug could unlock host of novel brain therapies

Nature Podcast

AI Chapters

AI Insights

Reviews